You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 00078-0608


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00078-0608

Drug NameNDCPrice/Unit ($)UnitDate
FOCALIN XR 25 MG CAPSULE 00078-0608-05 5.17258 EACH 2025-02-19
FOCALIN XR 25 MG CAPSULE 00078-0608-05 5.17470 EACH 2025-01-22
FOCALIN XR 25 MG CAPSULE 00078-0608-05 5.17507 EACH 2024-12-18
FOCALIN XR 25 MG CAPSULE 00078-0608-05 5.17358 EACH 2024-11-20
FOCALIN XR 25 MG CAPSULE 00078-0608-05 5.17292 EACH 2024-10-23
FOCALIN XR 25 MG CAPSULE 00078-0608-05 5.17122 EACH 2024-09-18
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 6 of 6 entries

Best Wholesale Price for NDC 00078-0608

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
FOCALIN XR 25MG CAP Novartis Pharmaceuticals Corporation 00078-0608-05 100 1367.60 13.67600 2020-09-01 - 2025-08-31 FSS
FOCALIN XR 25MG CAP Novartis Pharmaceuticals Corporation 00078-0608-05 100 1367.60 13.67600 2021-01-01 - 2025-08-31 FSS
FOCALIN XR 25MG CAP Sandoz, Inc. 00078-0608-05 100 1106.69 11.06690 2024-01-01 - 2028-08-14 FSS
FOCALIN XR 25MG CAP Sandoz, Inc. 00078-0608-05 100 1047.82 10.47820 2023-09-29 - 2028-08-14 FSS
FOCALIN XR 25MG CAP Novartis Pharmaceuticals Corporation 00078-0608-05 100 1032.42 10.32420 2021-01-01 - 2025-08-31 Big4
FOCALIN XR 25MG CAP Novartis Pharmaceuticals Corporation 00078-0608-05 100 960.51 9.60510 2020-09-01 - 2025-08-31 Big4
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 6 of 6 entries

Market Analysis and Price Projections for NDC 00078-0608

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug product. This code is essential for tracking and regulating drugs in the U.S. market[1][4].

Identifying the Drug

The NDC 00078-0608 corresponds to a specific drug product. However, without specific details on the drug name, we can infer general trends and factors that influence drug pricing and market dynamics.

Market Dynamics

Prescription vs. OTC Drugs

The market for prescription and over-the-counter (OTC) drugs is influenced by various factors, including regulatory approvals, consumer preferences, and economic conditions. For prescription drugs, the high development costs and stringent regulatory approvals can drive up prices. In contrast, OTC drugs are often more affordable and accessible, leading to a shift towards OTC options due to the high cost of prescription drugs[3].

Price Trends

Historically, prescription drug prices have seen significant increases. For example, from 2000 to 2008, 416 brand-name drug products experienced extraordinary price increases, with some prices rising by over 100% to as high as 2,000%[5].

Recent Price Increases

In 2022, the median price increase for brand-name drugs was 13.4%, which can serve as a benchmark for future price adjustments. This trend indicates that drug prices continue to rise, affecting both prescription and OTC markets[2].

Factors Influencing Price Projections

Regulatory Approvals

The FDA's approval process plays a critical role in drug pricing. Drugs approved through the New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) process undergo rigorous safety and efficacy evaluations, which can impact their pricing. The approval of new OTC drugs, such as Futura Medical's Eroxon and Harm Reduction Therapeutics' RiVive, can also influence market dynamics and prices[3].

Market Competition

The U.S. OTC drugs market is fragmented, with several major players like Johnson and Johnson, Novartis AG, Bayer AG, Sanofi SA, and Pfizer. Competition among these companies can affect pricing strategies, with companies often adjusting prices based on market conditions and competitor actions[3].

Consumer Behavior

Consumer behavior, particularly the shift towards OTC drugs due to the high cost of prescription drugs, is a significant factor. According to a study by the Kaiser Family Foundation, almost one in three U.S. individuals does not take medication as prescribed due to high costs, leading them to seek more affordable OTC alternatives[3].

Price Projections for NDC 00078-0608

Historical Pricing Data

To project future prices, historical pricing data for the specific NDC is essential. However, without specific data on NDC 00078-0608, we can infer from general trends. For instance, if the drug is a brand-name prescription drug, it may follow the median price increase trend of 13.4% observed in 2022[2].

Market Segment

The price projection also depends on the market segment the drug belongs to. For example, if it falls under the dermatology products category, which is expected to witness healthy growth, the price might be influenced by increased demand and new product approvals in this segment[3].

Example Price Projection Scenario

Assuming NDC 00078-0608 corresponds to a brand-name prescription drug with a current price per unit of $X, here is a hypothetical price projection:

  • Current Price: $X per unit
  • Historical Increase: 13.4% median increase in 2022
  • Projected Annual Increase: 10%-15% based on market trends and competition
  • Projected Price in 2025: $X (1 + 0.12) = $X 1.12

This is a simplified example and actual price projections would require detailed historical pricing data and specific market analysis.

Key Takeaways

  • NDC Importance: The NDC is crucial for identifying and tracking drug products in the U.S. market.
  • Market Trends: Prescription drug prices are rising, with a median increase of 13.4% in 2022.
  • Consumer Shift: High prescription drug costs are driving consumers towards OTC alternatives.
  • Regulatory Impact: FDA approvals and regulatory policies significantly influence drug pricing.
  • Competition: Market competition among major pharmaceutical companies affects pricing strategies.

FAQs

Q: What is the National Drug Code (NDC)? A: The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug product.

Q: Why are prescription drug prices increasing? A: Prescription drug prices are increasing due to high development costs, stringent regulatory approvals, and market competition.

Q: How does the FDA approval process affect drug pricing? A: The FDA approval process, including NDA and ANDA approvals, impacts drug pricing by ensuring safety and efficacy, which can drive up costs.

Q: What is driving the shift towards OTC drugs? A: The high cost of prescription drugs is leading consumers to seek more affordable OTC alternatives.

Q: How does market competition influence drug prices? A: Market competition among pharmaceutical companies can lead to price adjustments based on competitor actions and market conditions.

Sources

  1. FDA - National Drug Code Database Background Information
  2. DrugPatentWatch - Latest drug prices and trends for NDC 00378-2245
  3. GlobeNewswire - U.S. OTC Drugs Market Forecast Report 2024-2029
  4. FDA - National Drug Code Directory
  5. GAO - Brand-Name Prescription Drug Pricing

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.